This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

JOSEPH B. KIRSNER, M.D., Ph.D.; HAROLD FORD, B.S.

AMA Arch Intern Med. 1957;99(3):390-400.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Introduction

Experimental and clinical observations suggest that reserpine, the crystalline ester alkaloid of Rauwolfia serpentina, may stimulate gastric secretion and intestinal motility. Reserpine intravenously, in doses of 15 per kilogram, increased the volume of secretion and concentration of HCl in dogs with vagally denervated (Heidenhain) pouches ^1-3; the stimulating effect was suppressed by an anticholinergic drug but not by an antihistaminic. Intestinal motility increased after reserpine orally and intravenously in dogs but not in monkeys or rats. Clinically, reserpine, 1 mg. intravenously, stimulated the fasting gastric secretion in 24 patients^4,5; the presence or absence of duodenal ulcer and the control level of acidity did not influence the magnitude of the rise; the effect was apparent within 30 minutes after injection and continued for at least 4 hours. Similar results have been obtained by other investigators.^6,7 In contrast to previous findings, however, neither atropine nor methantheline bromide⁷ intravenously . . . [Full Text PDF of this Article]

Author Affiliations
Chicago

Department of Medicine, University of Chicago.

Footnotes
Submitted for publication July 6, 1956.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?